| Dr Dhruv Bansal, MD | |
|
12330 Metcalf Ave Ste 580, Overland Park, KS 66213-1308 | |
| (186) 932-3300 | |
| (816) 932-5793 |
| Full Name | Dr Dhruv Bansal |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 17 Years |
| Location | 12330 Metcalf Ave Ste 580, Overland Park, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023296209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2013016982 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Saint Lukes North Hospital | Kansas city, MO | Hospital |
| Saint Luke's South Hospital | Overland park, KS | Hospital |
| Saint Luke's East Hospital | Lees summit, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.
Doctors may soon be able to detect and monitor a patient's cancer with a simple blood test, reducing or eliminating the need for more invasive procedures, according to Purdue University research.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 9 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.
Doctors may soon be able to detect and monitor a patient's cancer with a simple blood test, reducing or eliminating the need for more invasive procedures, according to Purdue University research.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 9 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.
Doctors may soon be able to detect and monitor a patient's cancer with a simple blood test, reducing or eliminating the need for more invasive procedures, according to Purdue University research.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dhruv Bansal, MD 12330 Metcalf Ave Ste 580, Overland Park, KS 66213-1308 Ph: (816) 932-3300 | Dr Dhruv Bansal, MD 12330 Metcalf Ave Ste 580, Overland Park, KS 66213-1308 Ph: (186) 932-3300 |
News Archive
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.
Doctors may soon be able to detect and monitor a patient's cancer with a simple blood test, reducing or eliminating the need for more invasive procedures, according to Purdue University research.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 9 days ago
Dr. Matthew P Harrison, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 10116 W 105th St, Overland Park, KS 66212 Phone: 913-541-0510 Fax: 913-541-1852 | |
Louay K. Sabih, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10550 Marty St Ste 201, Overland Park, KS 66212 Phone: 913-341-4000 Fax: 913-383-2868 | |
Kimberly Foley Nagel, ARNP Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5701 W 119th St, Suite 345, Overland Park, KS 66209 Phone: 913-339-9046 Fax: 913-339-9018 | |
Dr. Paul G Diederich, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10787 Nall Ave, Ste. 310, Overland Park, KS 66211 Phone: 913-945-6900 Fax: 913-945-6970 | |
Mini R Abraham, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10000 College Blvd, Overland Park, KS 66210 Phone: 913-258-5055 Fax: 913-258-5057 | |
Jeena Viji Eapen, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 10540 Marty St Ste 100, Overland Park, KS 66212 Phone: 913-660-1616 Fax: 913-660-0998 | |
Dr. Arnold Leslie Katz, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 10550 Quivira Road, Suite 320, Overland Park, KS 66215 Phone: 913-888-3231 Fax: 913-888-7281 |